Every week, I speak with patients who have already been on a GLP-1 for three, six, sometimes twelve months. They have lost weight. They are also losing muscle. Their skin has softened in ways that concern them. They are not sleeping. They have plateaued. And no one — not the telehealth platform, not the med spa, not the primary care visit where the prescription was handed over in seven minutes — has addressed any of it.
This is not a GLP-1 problem. It is a protocol problem. The molecule works. The question is what surrounds it.
What GLP-1 actually does — and what it does not
Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro, Zepbound) are glucagon-like peptide-1 receptor agonists. They slow gastric emptying, reduce appetite signaling, and improve insulin sensitivity. In clinical trials, tirzepatide produced mean weight loss of 20–22% of body weight at 72 weeks. These are not placebo numbers.
What GLP-1 does not do: distinguish between fat tissue and lean muscle mass. Without deliberate intervention, a meaningful portion of weight lost on a GLP-1 — estimates range from 25–40% depending on the protocol — is lean mass. That is the tissue that determines your metabolic rate, your long-term body composition, and, frankly, how you look and move at 60.
Who is a good candidate for GLP-1 therapy near Charleston?
The FDA criteria are a BMI of 30 or above, or 27 with at least one weight-related comorbidity — hypertension, type 2 diabetes, or sleep apnea, among others. Clinical candidacy in my practice goes deeper than that. I want to know your metabolic panel, your inflammatory markers, your thyroid function, your body composition, and your history with prior weight loss attempts. I want to know what happened and why it did not hold.
There are patients for whom a GLP-1 is the cleanest tool available. There are others for whom it is one layer of a more complex protocol. And there are patients — those with a personal or family history of medullary thyroid carcinoma, or with certain pancreatic conditions — for whom it is contraindicated entirely. A prescription issued without this context is not medicine. It is a transaction.
Why muscle loss happens — and how we prevent it
GLP-1 agents reduce appetite significantly. That is the mechanism. The downstream consequence is that patients eat less protein, often far less than the threshold required to maintain muscle mass during a caloric deficit. Combined with reduced activity (which frequently accompanies early GLP-1 use, as some patients experience fatigue and GI adjustment), the result is accelerated lean mass loss.
At The Charleston Atelier, muscle preservation is built into the protocol from week one. This means:
- Protein targets calibrated to lean body mass, not generic RDA guidelines
- Titration that is paced to metabolic tolerance, not accelerated to maximize early weight numbers
- Peptide co-protocols when appropriate — compounds that support GH signaling and lean tissue maintenance
- Skin quality monitoring, with regenerative aesthetic options available for patients experiencing changes in facial volume or skin laxity
GLP-1 in Charleston: what to look for in a provider
Charleston has no shortage of GLP-1 prescribers in 2026. What it has less of is physician-supervised, longitudinally managed GLP-1 care. There is a difference between a prescription and a protocol, and it becomes visible around month three — when the honeymoon phase ends, the plateau arrives, and the patient is left to figure out what comes next.
When evaluating a GLP-1 provider near you, ask: Who is the physician of record? What happens when I plateau? Is there a plan for the off-ramp? What is being done to protect lean mass? If the answers are vague, that is the answer.
What to expect at your first GLP-1 consultation at The Charleston Atelier
Your initial visit is a physician consultation, not a sales call. We review your history, your labs (or order a baseline panel if you do not have recent ones), your body composition if indicated, and your goals — which are not always what they appear to be. Most patients say they want to lose weight. What they mean is they want to feel like themselves again, move without pain, fit into clothes they have kept for ten years, or live long enough to see their grandchildren graduate. That is what we are actually building toward.
The prescription, if appropriate, follows the consultation. The monitoring, the adjustments, the co-protocols, and the eventual off-ramp plan are built in from the start. That is what physician-led GLP-1 care looks like — in Charleston or anywhere else.
If you are considering GLP-1 therapy and want a protocol that treats the whole picture, I would be glad to meet you. The intake is two minutes, and the consultation is everything after that.
— Kendall Phelps-Polirer, MD · The Charleston Atelier · 83 Cannon Street, Charleston, SC